论文部分内容阅读
目的:评价3种方案干预治疗新生儿黄疸的经济学效果。方法:120例足月正常新生儿随机分为3组,分别给予退黄外洗液药浴(A组)、口服苯巴比妥+加味茵陈汤(B组)、口服苯巴比妥(C组)治疗6d后评价疗效及不良反应,并进行成本-效果分析。结果:A、B、C组总有效率分别为95.0%、92.5%、82.5%,总成本分别为259.20、131.88、127.38元,成本-效果比分别为272.84、142.57、154.40,A、B组增量成本-效果比分别为1054.56、45.00。A组黄疸出现时间较B、C组推迟约4h,且无不良反应。结论:B组方案在成本-效果比较中较优,但综合治疗比较中,A组方案较优且便于使用。
Objective: To evaluate the economic effects of three kinds of interventions on neonatal jaundice. Methods: A total of 120 full-term newborn infants were randomly divided into three groups: group A (medicated bath for excretion of external yellowish), group B for oral administration of phenobarbital (group B), oral administration of phenobarbital Group C) after 6 days of treatment efficacy and adverse reactions, and cost-effectiveness analysis. Results: The total effective rates of A, B and C groups were 95.0%, 92.5% and 82.5% respectively, the total costs were 259.20, 131.88 and 127.38 yuan, respectively. The cost-effectiveness ratios were 272.84, 142.57 and 154.40, The cost-effectiveness ratio is 1054.56,45.00 respectively. A group of jaundice than B, C delayed about 4h, and no adverse reactions. Conclusion: The B group scheme is better than the cost - effect comparison, but in the comprehensive treatment comparison, the A group scheme is superior and easy to use.